BAXTER HEALTHCARE CORPORATION for BAXTER HEALTHCARE CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
HR4213 -The tax Extenders Act of 2009; HR5297; The Small Business Jobs and Credit Act and HR 4853: The tax relief, unemployment Insurance Reauthorization and job Creation Act of 2010, as they related to the R&D tax credit ; S. 232 Device Tax Legislation. Device Tax Legislation.HR 3630, Middle Class Tax Relief and Job Creation Act (this is the payroll tax relief extension bill) S. 1813, MAP-21 Act (the Senate highway bill with pension relief) HR 4196 and S.2240, extension of bonus depreciation S.2240/HR 4196, to extend bonus depreciation; and S. 2237, the Small Business Jobs and Tax Relief Act, as it relates to bonus depreciation. S. 1813/HR 4348, MAP-21, as it relates to pension funding relief. Issues related to the R&D tax credit, the taxation of U.S. multinational corporations and corporate tax reform. S. 3521, The Family and Business Tax Cut Certainty Act of 2012, HR 8, the American Taxpayer Relief Act. H.Con.Res. 25 S.Con. Res. Budget Resolutions S.886, S. 1013, H.R.845, H.R. 2024 Intellectual Property
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK MANIKO | — |
| JED PERRY | — |
| JOSEPH V SCHWAN | — |
Health Issues HCR
340B Drug Discount; FDA Regulatory Environment. Raise awareness with legislators about the benefits of home dialysis and try to increase awareness in the veteran population. Disease registry for Mutifocal Motor NeuropathyRaise Awareness with legislators about survey and certification issues as it relates to home dialysis. Seeking appropriate reimbursement and access for an investigational indication of our product, GammaGard, to treat Alzheimers Disease. S. 959 Pharmaceutical Quality Security: Accountability Act H.R. 1919 Safeguarding America's Pharmaceuticals Act Compounding : Traceability reforms
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK COIN | — |
| JACK MANIKO | — |
| KELLI MILLS LESTER | — |
| JED PERRY | — |
Medicare/Medicaid MMM
Legislation to cut Medicare Part B Drug Reimbursement Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis.HR 3613: Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure. Medicare Part B Drug Reimbursement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK COIN | — |
| JACK MANIKO | — |
| KELLI MILLS LESTER | — |
| JED PERRY | — |
| JOSEPH V SCHWAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.